These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 33776574)

  • 1. Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality.
    Cusacovich I; Aparisi Á; Marcos M; Ybarra-Falcón C; Iglesias-Echevarria C; Lopez-Veloso M; Barraza-Vengoechea J; Dueñas C; Juarros Martínez SA; Rodríguez-Alonso B; Martín-Oterino JÁ; Montero-Baladia M; Moralejo L; Andaluz-Ojeda D; Gonzalez-Fuentes R
    Mediators Inflamm; 2021; 2021():6637227. PubMed ID: 33776574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
    Chen Q; Song Y; Wang L; Zhang Y; Han L; Liu J; Yang M; Ma J; Wang T
    Expert Rev Respir Med; 2021 Apr; 15(4):543-552. PubMed ID: 33249945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
    Liu Z; Li X; Fan G; Zhou F; Wang Y; Huang L; Yu J; Yang L; Shang L; Xie K; Xu J; Huang Z; Gu X; Li H; Zhang Y; Wang Y; Huang Z; Cao B
    Clin Microbiol Infect; 2021 Jan; 27(1):112-117. PubMed ID: 33007478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study.
    Li Y; Meng Q; Rao X; Wang B; Zhang X; Dong F; Yu T; Li Z; Feng H; Zhang J; Chen X; Li H; Cheng Y; Hong X; Wang X; Yin Y; Zhang Z; Wang D
    Crit Care; 2020 Dec; 24(1):698. PubMed ID: 33339536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients.
    Mandadi S; Pulluru H; Annie F
    PLoS One; 2022; 17(2):e0264301. PubMed ID: 35196344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Analysis of Hyperlipidemia with the 28-Day All-Cause Mortality of COVID-19 in Hospitalized Patients.
    Wu B; Zhou JH; Wang WX; Yang HL; Xia M; Zhang BH; She ZG; Li HL
    Chin Med Sci J; 2021 Mar; 36(1):17-26. PubMed ID: 33853705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.
    Wu J; Huang J; Zhu G; Liu Y; Xiao H; Zhou Q; Si X; Yi H; Wang C; Yang D; Chen S; Liu X; Liu Z; Wang Q; Lv Q; Huang Y; Yu Y; Guan X; Li Y; Nirantharakumar K; Cheng K; Peng S; Xiao H
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32880390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a Target Trial Emulation Framework vs Cox Regression to Estimate the Association of Corticosteroids With COVID-19 Mortality.
    Hoffman KL; Schenck EJ; Satlin MJ; Whalen W; Pan D; Williams N; Díaz I
    JAMA Netw Open; 2022 Oct; 5(10):e2234425. PubMed ID: 36190729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
    Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
    PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of corticosteroid in patients with COVID-19: A multi-center retrospective study and meta-analysis.
    Zhan Y; Shang J; Gu Y; Huang Q; Xie J
    J Med Virol; 2021 Jul; 93(7):4292-4302. PubMed ID: 33666250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements.
    Tortajada C; Colomer E; Andreu-Ballester JC; Esparcia A; Oltra C; Flores J
    J Med Virol; 2021 Mar; 93(3):1817-1823. PubMed ID: 33107607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).
    Rodríguez-Baño J; Pachón J; Carratalà J; Ryan P; Jarrín I; Yllescas M; Arribas JR; Berenguer J; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Clin Microbiol Infect; 2021 Feb; 27(2):244-252. PubMed ID: 32860964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients.
    Albani F; Fusina F; Granato E; Capotosto C; Ceracchi C; Gargaruti R; Santangelo G; Schiavone L; Taranto MS; Tosati C; Vavassori E; Natalini G
    Sci Rep; 2021 Jan; 11(1):1015. PubMed ID: 33441909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients.
    Bahl A; Johnson S; Chen NW
    Intern Emerg Med; 2021 Sep; 16(6):1593-1603. PubMed ID: 33547620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response.
    López Zúñiga MÁ; Moreno-Moral A; Ocaña-Granados A; Padilla-Moreno FA; Castillo-Fernández AM; Guillamón-Fernández D; Ramírez-Sánchez C; Sanchez-Palop M; Martínez-Colmenero J; Pimentel-Villar MA; Blázquez-Roselló S; Moreno-Sánchez JJ; López-Vílchez M; Prior-Sánchez I; Jódar-Moreno R; López Ruz MÁ
    PLoS One; 2021; 16(1):e0243964. PubMed ID: 33507958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
    Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
    J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19.
    Lafaurie M; Martin-Blondel G; Delobel P; Kamar N; Charpentier S; Sommet A; Moulis G;
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):14. PubMed ID: 33706794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.